ASCO Guidelines
A podcast by American Society of Clinical Oncology (ASCO)
180 Episoade
-
Adjuvant Therapy for Stage II Colon Cancer Guideline Update
Publicat: 22.12.2021 -
Management of Stage III NSCLC Guideline
Publicat: 22.12.2021 -
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
Publicat: 21.12.2021 -
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline
Publicat: 13.12.2021 -
Abemaciclib with Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update
Publicat: 10.12.2021 -
Considerations for the Use of Steroids: Management of irAEs Guideline (Part 13)
Publicat: 16.11.2021 -
Ocular Toxicities: Management of irAEs Guideline (Part 12)
Publicat: 15.11.2021 -
Cardiovascular Toxicities: Management of irAEs Guideline (Part 11)
Publicat: 12.11.2021 -
Hematologic Toxicities: Management of irAEs Guideline (Part 10)
Publicat: 11.11.2021 -
Nervous System Toxicities: Management of irAEs Guideline (Part 9)
Publicat: 10.11.2021 -
Renal Toxicities: Management of irAEs Guideline (Part 8)
Publicat: 09.11.2021 -
Musculoskeletal Toxicities: Management of irAEs Guideline (Part 7)
Publicat: 08.11.2021 -
Endocrine Toxicities: Management of irAEs Guideline (Part 6)
Publicat: 05.11.2021 -
Lung Toxicities: Management of irAEs Guideline (Part 5)
Publicat: 04.11.2021 -
Gastrointestinal Toxicities: Management of irAEs Guideline (Part 4)
Publicat: 03.11.2021 -
Cutaneous Toxicities: Management of irAEs Guideline (Part 3)
Publicat: 02.11.2021 -
ICPi Overview: Management of irAEs Guideline (Part 1)
Publicat: 01.11.2021 -
CAR-T Cell Therapy: Management of irAEs Guideline (Part 2)
Publicat: 01.11.2021 -
Immunotherapy in Patients with Locally Advanced Esophageal Carcinoma: ASCO Guideline Rapid Recommendation Update
Publicat: 18.08.2021 -
Adjuvant PARP Inhibitors in Patients with High-risk Early-Stage HER2-Negative Breast Cancer and Germline BRCA Mutations: ASCO Hereditary Breast Cancer Guideline Rapid Recommendation Update
Publicat: 03.08.2021
Explore pivotal recommendations from the latest evidence-based clinical practice guidance with ASCO Guidelines. Join us to discover essential insights and navigate the ever-evolving landscape of cancer research and treatment.
